The notices it replaced
10 notices, oldest first, each with its awards since FY2014.
- Year not statedRFA-CA-05-003None since FY2014
- Year not statedRFA-CA-06-003None since FY2014
- Year not statedRFA-CA-07-002None since FY2014
- Year not statedRFA-CA-07-018None since FY2014
- Year not statedRFA-CA-07-036None since FY2014
- Year not statedRFA-CA-08-008None since FY2014
- Posted 2008RFA-CA-09-007None since FY2014
- Posted 2009RFA-CA-10-004None since FY2014
- Posted 2011RFA-CA-12-003None since FY2014
- Posted 2012RFA-CA-13-0026 awards
- Posted 2013RFA-CA-14-004This notice, closed · 12 awards
Replaced by RFA-CA-15-003.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 18
- 18 new
- Median first-year cost
- $378,127
- $6,848,448 in all
- Institutions
- 17
- 18 contact PIs
- Patents
- 4
- from 3 funded projects
Awards by fiscal year
6
12
0
0
0
0
0
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- UNIVERSITY OF WASHINGTON2
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
- BIOSPYDER TECHNOLOGIES, INC.1
- CORNELL UNIVERSITY1
- DUKE UNIVERSITY1
and 12 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 TCRB-Q (J1))5
- Special Emphasis Panel (ZCA1 SRLB-Q (J2))4
- Special Emphasis Panel (ZCA1 TCRB-Q (O2))4
- Special Emphasis Panel (ZCA1 TCRB-5 (M1))3
- Special Emphasis Panel (ZCA1 SRLB-Q (M2))2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2015 | Single cell cytokine analysis of circulating malignant hematopoietic cells1R33CA196411-01 | Fan, RongLevine, Ross L | YALE UNIVERSITY, CT | First-year cost $421,227 | Study section ZCA1 |
| FY2015 | High-throughput on-chip platform for interrogation of mitochondrial membrane potential and apoptosis1R33CA182384-01A1 | Burke, Peter J. | UNIVERSITY OF CALIFORNIA-IRVINE, CA | First-year cost $412,541 | Study section ZCA1 |
| FY2015 | Noninvasive detection of circulating RNAs for lung cancer early detection and prognosis1R33CA191245-01A1 | Wu, Yun | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | First-year cost $411,504 | Study section ZCA1 |
| FY2015 | Development of a virion display (VirD) array to profile human GPCR interactions1R33CA186790-01A1 | Desai, Prashant JZhu, Heng | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $403,372 | Study section ZCA1 |
| FY2015 | A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple Oncogenes1R33CA191198-01 | Caron, Marc G. | DUKE UNIVERSITY, NC | First-year cost $389,963 | Study section ZCA1 |
| FY2015 | Using Adductomics to Characterize Exposures to Carcinogens1R33CA191159-01A1 | Rappaport, Stephen Morris | UNIVERSITY OF CALIFORNIA BERKELEY, CA | First-year cost $380,395 | Study section ZCA1 |
| FY2015 | Advanced development and validation of targeted molecular counting methods for precise and ultrasensitive quantitation of low prevalence somatic mutations1R33CA192980-01 | Salipante, Stephen J | UNIVERSITY OF WASHINGTON, WA | First-year cost $375,858 | Study section ZCA1 |
| FY2015 | Scalable Cancer Genomics via Nanocoding and Sequencing1R33CA182360-01A1 | Ma, JianSchwartz, David C. | UNIVERSITY OF WISCONSIN-MADISON, WI | First-year cost $372,503 | Study section ZCA1 |
| FY2015 | Fast interference-based super-resolution microscope for cancer mechanobiology1R33CA193043-01 | Zipfel, Warren R | CORNELL UNIVERSITY, NY | First-year cost $364,273 | Study section ZCA1 |
| FY2015 | Single cell growth assay for residual cells in acute lymphoblastic leukemia1R33CA191143-01 | Manalis, Scott R | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | First-year cost $363,946 | Study section ZCA1 |
| FY2015 | RASL-Seq Expression Profiling of FFPE Tissues1R33CA183688-01A1 | Yeakley, Joanne Mulligan | BIOSPYDER TECHNOLOGIES, INC., CA | First-year cost $363,706 | Study section ZCA1 |
| FY2015 | Validation and Advanced Development of Glycan Node Analysis in Lung Cancer Research1R33CA191110-01 | Borges, Chad R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | First-year cost $317,654 | Study section ZCA1 |
| FY2014 | Integrating mass cytometric and transcriptomic profiles of solid tumors1R33CA183692-01 · under RFA-CA-13-002 | Weiss, William A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $408,712 | Study section ZCA1 |
| FY2014 | Large-Scale Characterization of Anti-Cancer Antibody Responses in Lung Adenocarci1R33CA183659-01 · under RFA-CA-13-002 | Robinson, William H | STANFORD UNIVERSITY, CA | First-year cost $399,643 | Study section ZCA1 |
| FY2014 | Validation and Advanced Development of Duplex Sequencing1R33CA181771-01A1 · under RFA-CA-13-002 | Loeb, Lawrence A | UNIVERSITY OF WASHINGTON, WA | First-year cost $384,923 | Study section ZCA1 |
| FY2014 | Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics1R33CA177333-01A1 · under RFA-CA-13-002 | Federspiel, Mark J | MAYO CLINIC ROCHESTER, MN | First-year cost $375,008 | Study section ZCA1 |
| FY2014 | Non-Circulating Microparticles for Improved Localization and Resection Cancer1R33CA177449-01A1 · under RFA-CA-13-002 | Blair, Sarah L | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | First-year cost $361,766 | Study section ZCA1 |
| FY2014 | Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Sp1R33CA183671-01 · under RFA-CA-13-002 | Parker, Laurie L. | UNIVERSITY OF MINNESOTA, MN | First-year cost $341,454 | Study section ZCA1 |
Newest fiscal year first, then first-year cost.
Patents from its funded projects
4 patents name 3 of the 18 funded projects.
- US 12,560,590 (opens the patent at USPTO, a PDF, in a new tab)RAPID ANALYSIS OF LIVE CELLSGranted February 24, 2026 to Massachusetts Institute of Technology and Dana-Farber Cancer Institute, Inc.R33CA191143 · MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA
- US 11,808,701 (opens the patent at USPTO, a PDF, in a new tab)SYSTEMS AND METHODS FOR IDENTIFYING SEQUENCE INFORMATION FROM SINGLE NUCLEIC ACID MOLECULE MEASUREMENTSGranted November 7, 2023 to Wisconsin Alumni Research FoundationR33CA182360 · UNIVERSITY OF WISCONSIN-MADISON, WI
- US 10,883,992 (opens the patent at USPTO, a PDF, in a new tab)Universal Kinase Substrates and Methods of Use ThereofGranted January 5, 2021 to Regents of the University of Minnesota and Yale UniversityR33CA183671 · UNIVERSITY OF MINNESOTA, MN
- US 10,760,113 (opens the patent at USPTO, a PDF, in a new tab)Kinase Activity Detection MethodsGranted September 1, 2020 to Regents of the University of Minnesota and PURDUE RESEARCH FOUNDATIONR33CA183671 · UNIVERSITY OF MINNESOTA, MN
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.